V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004962 | 330002392 | 1.76 | 0 | Curative (C) | 2016-04-21 | 2016-04-27 | CNS HGG Temozolomide +XRT | 2 | N | 330020937 | UKALL XII |
| 330004963 | 330002393 | 1.55 | 52 | Palliative (P) | 2016-01-05 | 2016-01-08 | CISPLATIN + DOXORUBICIN + ETOPOSIDE | N | N | 330020942 | VINBLASTINE |
| 330004964 | 330002394 | 1.74 | 58.8 | Curative (C) | null | 2017-07-07 | Cisplatin + Docetaxel | null | null | 330020955 | HYDROXYCARBAMIDE |
| 330004965 | 330002394 | 1.76 | 85 | Adjuvant (A) | 2014-05-27 | 2014-08-05 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | N | 330020955 | CARBOPLATIN + RT |
| 330004966 | 330002395 | 0 | 0 | Adjuvant (A) | 2013-08-16 | 2013-08-18 | ECX | 2 | N | 330020967 | OXALIPLATIN + MDG |
| 330004967 | 330002395 | 1.68 | 112 | Palliative (P) | 2017-04-24 | 2017-05-03 | LIPOSOMAL DAUNORUBICIN | N | N | 330020967 | VIDE |
| 330004972 | 330012248 | 1.78 | 115.2 | Palliative (P) | 2014-10-31 | 2014-11-01 | FLAG + Idarubicin | N | N | 330020980 | CETUXIMAB + CISPLATIN + FU |
| 330004973 | 330012248 | 1.7 | 76.9 | Curative (C) | 2018-01-07 | 2018-01-16 | Cytarabine Low Dose | N | N | 330020980 | DACARBAZINE |
| 330004974 | 330002397 | 0 | 109 | Palliative (P) | 2013-12-02 | 2013-12-07 | CAPECITABINE + RT | N | N | 330020988 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 330004975 | 330002398 | 1.68 | 67.5 | Palliative (P) | null | 2014-04-27 | VISMODEGIB | N | N | 330020998 | CARBOPLATIN + RT |
| 330004976 | 330002399 | null | 86.3 | null | 2016-10-08 | 2016-10-14 | VIDE | null | N | 330021001 | CARBOPLATIN + VINORELBINE |
| 330004977 | 330002399 | null | 108 | null | 2017-02-26 | 2017-03-02 | Sunitinib | N | N | 330021001 | CETUXIMAB + CISPLATIN + FU |
| 330004978 | 330002399 | 1.06 | 0 | Curative (C) | 2014-11-10 | 2014-11-16 | Bevacizumab 7.5mg/kg | N | N | 330021001 | CARBOPLATIN + RT |
| 330004979 | 330002399 | 1.63 | null | Adjuvant (A) | 2018-01-06 | 2018-01-06 | IBRUTINIB | 2 | N | 330021001 | HERBY TRIAL |
| 330004980 | 330002399 | null | 51.7 | Curative (C) | 2015-07-07 | 2015-09-11 | Cytarabine High Dose | N | Y | 330021001 | DOXORUBICIN + IFOSFAMIDE |
| 330004981 | 330002399 | 0 | null | Palliative (P) | 2015-07-21 | 2015-08-18 | Mitotane 2g | N | N | 330021001 | CISPLATIN + DOX + ETOPOSIDE + MITOTANE |
| 330004982 | 330002399 | 1.5 | 99.3 | Adjuvant (A) | 2015-01-01 | 2015-01-08 | CNS HGG Temozolomide +XRT | N | N | 330021001 | CISPLATIN + DOX + ETOPOSIDE |
| 330004983 | 330002399 | 1.72 | 87.4 | Curative (C) | 2013-07-21 | 2013-07-27 | METHOTREXATE | N | N | 330021001 | ECX |
| 330004984 | 330002399 | 1.55 | 15 | Palliative (P) | null | 2018-03-21 | EP | 2 | N | 330021001 | CISPLATIN + VINORELBINE |
| 330004985 | 330002400 | 1.85 | 83 | Palliative (P) | 2014-10-21 | 2014-10-28 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330021029 | CAPECITABINE + CARBOPLATIN |
| 330004986 | 330002400 | null | 96.7 | Palliative (P) | 2015-07-17 | 2015-07-29 | Azacitidine | 02 | N | 330021029 | CYTARABINE |
| 330004987 | 330002400 | 1.61 | 51.3 | Palliative (P) | 2013-02-15 | 2013-02-23 | Doxorubicin + Ifosfamide | N | N | 330021029 | CISPLATIN + DOCETAXEL |
| 330004988 | 330002400 | 0 | 72.6 | Palliative (P) | 2016-05-07 | 2016-05-08 | Cisplatin+Doxorubicin+Etoposide 21d | N | N | 330021029 | VIDE |
| 330004989 | 330002400 | 1.51 | null | Curative (C) | 2017-03-22 | 2017-03-22 | VAI (Ifos 3g/m2) | N | null | 330021029 | CISPLATIN + FLUOROURACIL + RT |
| 330004990 | 330002401 | 1.53 | 61.9 | Palliative (P) | 2014-10-07 | 2014-10-08 | CARBOPLATIN + RT | N | null | 330021046 | MIFAMURTIDE |
| 330004991 | 330002402 | 1.7 | 108.9 | Palliative (P) | 2014-09-04 | 2014-10-06 | Vincristine (weekly) | N | N | 330021048 | VEPEMB |
| 330004992 | 330002402 | 1.74 | 89.4 | Palliative (P) | 2016-10-27 | 2016-10-27 | CHLORAMBUCIL + RITUXIMAB | 2 | N | 330021048 | MELPHALAN |
| 330004993 | 330002403 | 1.5 | 62.1 | Curative (C) | 2014-03-20 | 2014-03-21 | FLAG + Idarubicin | null | null | 330021056 | PEMBROLIZUMAB |
| 330004994 | 330007322 | 1.67 | 64.1 | Palliative (P) | 2017-10-08 | 2017-11-17 | FLUOROURACIL + MITOMYCIN | 02 | null | 330021058 | DOCETAXEL + GEMCITABINE |
| 330004995 | 330002404 | 1.74 | null | null | 2013-04-01 | 2013-04-01 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | N | N | 330021059 | DABRAFENIB |
| 330004996 | 330002405 | 1.6 | 60.2 | Curative (C) | 2014-11-16 | 2014-12-06 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 330021060 | DOCETAXEL + GEMCITABINE |
| 330004997 | 330002406 | 1.82 | null | Palliative (P) | 2013-07-12 | 2013-07-13 | VIDE | null | N | 330021071 | CARBOPLATIN + RT |
| 330004998 | 330007323 | 1.58 | 14.8 | Palliative (P) | 2017-06-06 | 2017-06-09 | CARBOPLATIN + RT | 02 | Y | 330021074 | FEC + DOCETAXEL |
| 330004999 | 330007323 | 1.86 | 25.3 | Curative (C) | 2018-03-20 | 2018-03-27 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 330021074 | CISPLATIN + VINORELBINE |
| 330005000 | 330007323 | 1.55 | null | Curative (C) | 2014-07-22 | 2014-07-24 | Hydroxycarbamide | 99 | Y | 330021074 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 330005001 | 330007323 | 1.77 | 79.3 | Curative (C) | null | 2014-07-14 | Chlorambucil | Y | Y | 330021074 | CARBOPLATIN + RT |
| 330005002 | 330007323 | 1.55 | null | null | 2015-05-14 | 2015-05-15 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 330021074 | OXALIPLATIN + MDG |
| 330005003 | 330007323 | 1.72 | 51 | Curative (C) | 2013-03-28 | 2013-04-02 | Mitomycin + MdG | 2 | N | 330021074 | PACLITAXEL |
| 330005004 | 330007323 | null | 108 | Adjuvant (A) | 2013-12-27 | 2013-12-27 | VAI (Ifos 3g/m2) | Y | null | 330021074 | ENZALUTAMIDE |
| 330005005 | 330007323 | 1.81 | 57.9 | Curative (C) | 2014-09-03 | 2014-09-21 | Cisplatin + Pemetrexed | N | N | 330021074 | UKALL2011 |
| 330005007 | 330002408 | null | 56.05 | null | 2017-12-13 | 2017-12-27 | Capecitabine 35days + RT | N | N | 330021104 | BEVACIZUMAB + IRINOTECAN + TEMOZOLOMIDE |
| 330005008 | 330002409 | 1.57 | null | null | 2013-02-13 | 2013-02-14 | Bexarotene | 2 | N | 330021108 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330005009 | 330002409 | 1.71 | 12.1 | Curative (C) | 2017-07-25 | 2017-08-16 | OST Mifamurtide | 02 | N | 330021108 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 330005010 | 330002409 | null | 56.6 | Curative (C) | 2014-12-03 | 2014-12-03 | Cisplatin + Vinorelbine (IV) | N | N | 330021108 | CISPLATIN + VINORELBINE |
| 330005011 | 330002409 | 0 | 91.8 | Palliative (P) | 2016-08-24 | 2016-09-13 | VAC | null | null | 330021108 | VEMURAFENIB |
| 330005012 | 330002409 | 1.5 | 48.6 | Palliative (P) | null | 2015-08-01 | Oxaliplatin + Modified de Gramont | 02 | null | 330021108 | CISPLATIN + VINORELBINE |
| 330005013 | 330002410 | null | 56.3 | Adjuvant (A) | 2014-10-20 | 2014-10-26 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 330021122 | CHOP R |
| 330005014 | 330002411 | null | 39.5 | Palliative (P) | 2018-03-28 | 2018-04-03 | ALL UKALL60+ TRIAL | 02 | N | 330021126 | CMV |
| 330005015 | 330002412 | null | 89 | Curative (C) | 2015-08-24 | 2015-08-28 | Hydroxycarbamide | N | N | 330021128 | BEP |
| 330005016 | 330002413 | 1.75 | 50 | Palliative (P) | 2017-09-18 | 2017-09-22 | Azacitidine | N | N | 330021132 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |